NHS Bury Primary Care Trust Goes Live with iSOFT Lorenzo RC 1.9

iSOFTiSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced the implementation of the latest version of its Lorenzo electronic patient record solution at NHS Bury Primary Care Trust (PCT) in Lancashire. NHS Bury went live on 3 November with iSOFT's Lorenzo Regional Care 1.9.

The trust, through Local Service Provider CSC, is using Lorenzo Regional Care 1.9 for referral and caseload management as well as inpatient and outpatient functionality, supporting almost 600 community-based clinical and administrative users working across two wards and 1,200 clinics. The trust has plans to introduce clinical functionality in the coming months by using assessment functionality for orthopaedics and dietetics.

Gary Cohen, iSOFT's Executive Chairman & CEO, said: "The company is committed to helping trusts meet the IT goals set forward by the Department of Health Informatics Directorate and will remain diligent in ensuring they successful manage migrations from existing systems to Lorenzo. Bury PCT demonstrates a significant step forward for Lorenzo's strategic role within the National Programme for IT. The implementation teams have shown tenacity and determination to deliver a successful go-live and we are looking forward to further go-lives with this Trust, and a number of others, in the near future."

Adrian Stevens, Managing Director of iSOFT's UK and Ireland business, says the company remains committed to actively working with partner CSC on the delivery of Lorenzo Regional Care under the North, Midlands and East Programme for IT. "The Bury trust go-live is a particularly important achievement, both for iSOFT as well the National Programme, because this latest version of Lorenzo takes the efficient provision of healthcare in England to a new level. We will be closely monitoring the deployment at Bury over the coming weeks to ensure the system works well as staff continue to use this on a daily basis. We look forward to working with CSC and the NHS as we progress with this and further successful deployments. Looking beyond the success at Bury, iSOFT continues to actively support both CSC and NHS Connecting for Health in achieving the goals of the NPfIT and core IT strategy by continuing to deliver Lorenzo to the contracted regions in England," he said.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group’s sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 18 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organisational structure.

www.isofthealth.com

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...